Exesalibero Pharma, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMorgantown, WV
SAM.gov UEIHVMJC4FQ8RM7
ExesaLibero Pharma develops small-molecule drugs to treat bone disease, with a current focus on completing preclinical toxicology and efficacy studies for a drug designed to control bone erosion associated with conditions including rheumatoid arthritis, multiple myeloma, diabetes, periodontal disease, and tuberculosis. The company's results from these studies will support an Investigative New Drug application to the FDA, with the goal of initiating clinical trials following IND approval.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Exesalibero Pharma, INC | Morgantown | WV | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.